| MolName | (2Z)-2-[3-(4-bromophenyl)-5-[(2,5-dichlorophenyl)methyl]-4-oxo-1,3-thiazolidin-2-ylidene]-2-cyanoacetamide |
| MolecularFormula | C19H12N3O2BrCl2S |
| Smiles | NC(/C(/C#N)=C(/N1c(cc2)ccc2Br)\SC(Cc(cc(cc2)Cl)c2Cl)C1=O)=O |
| InChI | InChI=1S/C19H12BrCl2N3O2S/c20-11-1-4-13(5-2-11)25-18(27)16(28-19(25)14(9-23)17(24)26)8-10-7-12(21)3-6-15(10)22/h1-7,16H,8H2,(H2,24,26)/t16-/m1/s1 |
| InChIK | XIAIROJPQBTZAC-MRXNPFEDSA-N |
| TotalMolweight | 497.199 |
| Molweight | 497.199 |
| MonoisotopicMass | 494.921062 |
| CLogP | 4.5921 |
| CLogS | -6.697 |
| H Acceptors | 5 |
| H Donors | 1 |
| TotalSurfaceArea | 311.69 |
| Relative PSA | 0.24367 |
| PolarSurfaceArea | 112.49 |
| Druglikeness | -0.54767 |
| Mutagenic | none |
| Tumorigenic | high |
| Reproductive Effective | high |
| Irritant | none |
| Nasty Functions | polar activated DB; twice activated DB |
| Shape Index | 0.46429 |
| Fragments | 1 |
| Non HAtoms | 28 |
| NonCHAtoms | 9 |
| Electronegative Atoms | 9 |
| StereoCenters | 1 |
| Rotatable Bond | 4 |
| Rings Closures | 3 |
| Small Rings | 3 |
| Aromatic Rings | 2 |
| Aromatic Atoms | 12 |
| Sp3Atoms | 3 |
| Symmetricatoms | 2 |
| Amides | 2 |
| StereoCon | racemate |
Click to Load Molecule:
1 - (2Z)-2-[3-(4-bromophenyl)-5-[(2,5-dichlorophenyl)methyl]-4-oxo-1,3-thiazolidin-2-ylidene]-2-cyanoacetamide | 2 - (2Z)-2-[3-(4-bromophenyl)-5-[(2,5-dichlorophenyl)methyl]-4-oxo-1,3-thiazolidin-2-ylidene]-2-cyanoacetamide